Validation of a Combined Prognostic Score Using Plasma Tumor DNA and Clinical Features in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Taxanes
The prognostic score has confirmed to be a good prognostic tool also in a more advanced cohort of patients treated with taxanes. This tool may represent a valid method to refine prognostication and treatment selection in a cohort of patients where biomarkers are scarce.
Authors
- Emanuela Scarpi (ORCID: https://orcid.org/0000-0001-7230-9267)
- Cristian Lolli (ORCID: https://orcid.org/0000-0003-0347-9179)
- Vincenza Conteduca (ORCID: https://orcid.org/0000-0002-6921-714X)
- Giuseppe Schepisi (ORCID: https://orcid.org/0000-0002-9973-4869)
- Paola Caroli
- Federica Matteucci (ORCID: https://orcid.org/0000-0001-7455-6253)
- Nicole Brighi (ORCID: https://orcid.org/0000-0002-1187-5481)
Institutions
- University of Foggia (IT)
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- OncoTargets and Therapy
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/ott.s509285
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministero della Salute